Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease.

Ítems similars

• Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation.
  per: Babé, L M, et al.
  Publicat: (1995)
• Constitutive production of nonenveloped human immunodeficiency virus type 1 particles by a mammalian cell line and effects of a protease inhibitor on particle maturation.
  per: Babé, L M, et al.
  Publicat: (1994)
• Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity.
  per: Rosé, J R, et al.
  Publicat: (1995)
• Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor.
  per: Poppe, S M, et al.
  Publicat: (1997)
• Engineering human immunodeficiency virus 1 protease heterodimers as macromolecular inhibitors of viral maturation.
  per: McPhee, F, et al.
  Publicat: (1996)